Nature, Published online: 05 March 2025; doi:10.1038/d41586-025-00546-w

Current approaches to pain relief are falling short. Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking drug tolerance or psychoactivity.